Olfactomedin 4 as a urinary biomarker to predict AKI and need for renal replacement therapy
Sunday, April 30, 2023
8:00 AM – 8:15 AM ET
Location: Convention Center: 209 A
Publication Number: 2040.1
Imogen Clover-Brown, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Denise Hasson, New York University Grossman School of Medicine, New York, NY, United States; Kristalynn M. Kempton, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Kelli A. Krallman, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Stuart L. Goldstein, Cincinnati Children's Hospital, Cincinnati, OH, United States; Matthew N. Alder, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States
Presenting Author(s)
Imogen Clover-Brown, MD (she/her/hers)
Pediatric Resident, PL2 Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
Disclosure(s):
Imogen Clover-Brown, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Denise Hasson, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kristalynn M. Kempton, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kelli A. Krallman, RN, BSN, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Stuart L. Goldstein, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Matthew N. Alder, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
